Basic Desyrel Information

• INN (International Nonproprietary Name): Trazodone.
• Brand Names Available In Canada (English): Not specified.
• ATC Code: N06AX05.
• Forms & Dosages: Tablets in 50 mg, 100 mg, 150 mg and 300 mg strengths, and oral solution at about 10 mg/mL in some markets.
• Manufacturers In Canada (English): Pfizer is the original developer; Angelini Pharma supplies Trittico in Europe; generic manufacturers listed in regulatory data include Teva, Sandoz, Mylan, Torrent, Sun Pharma and KRKA.
• Registration Status In Canada (English): Not specified.
• OTC / Rx Classification: Prescription-only globally; never OTC.

Major 2022–2025 Canadian & Global Studies

Main Outcomes

Patients and prescribers have focused recent research on two areas: low-dose trazodone for insomnia and controlled-release formulations for major depressive disorder.

Meta-analyses and pooled observational studies from 2022–2025 show trazodone remains effective as an antidepressant at standard therapeutic doses, with starting doses around 150 mg/day and titration to 400 mg/day or higher in severe cases.

Lower bedtime doses in the 25–100 mg range are commonly effective for sleep disturbance in outpatient settings, and many clinicians report improved sleep continuity at these doses.

Extended-release and prolonged-release products address daytime sedation and support once- or twice-daily schedules for depression treatment.

Formulation availability in registries mirrors study doses, with tablets and oral solutions used for flexible titration in practice.

Safety Observations

Safety data from 2022–2025 reiterate known risks: orthostatic hypotension and sedation are prominent, especially in older adults.

Rare but serious events such as cardiac arrhythmias and priapism continue to appear in case reports and pharmacovigilance databases.

Canadian provincial pooled adverse-event reporting echoes international signals, noting higher falls and hospital visits in frail seniors when trazodone is combined with other sedatives.

Regulatory summaries retain contraindications for recent MAOI use and acute post-myocardial infarction recovery.

Clinicians are trending toward personalised dosing and close monitoring in polypharmacy situations.

Layman’s Explanation

People ask, "How does desyrel help me sleep or my mood?"

Trazodone helps balance brain chemicals related to mood and sleep, which is why a single medicine can help with depression and also make it easier to fall and stay asleep.

At low bedtime doses, most people feel the sedating effect quickly, often the first night.

Scientific Breakdown

Trazodone is a serotonin antagonist and reuptake inhibitor, abbreviated as SARI.

The drug moderately inhibits serotonin reuptake while antagonising 5-HT2A and 5-HT2C receptors, which contributes to anxiolytic and sleep-architecture effects.

Antihistamine H1 activity and alpha-1 adrenergic blockade explain daytime and nighttime sedation and orthostatic hypotension.

Metabolism is hepatic with CYP involvement, notably CYP3A4, so inhibitors or inducers of that enzyme can change trazodone exposure.

Pharmacokinetics support once-to-twice-daily dosing for depression and single nightly dosing for insomnia with immediate-release formulations, while extended-release options like Oleptro exist in other markets.

Health Canada Approvals (DIN-Based)

Health Canada classifies trazodone as prescription-only for major depressive disorder consistent with international product licences.

Approved product listings in Canada are DIN-based and pharmacists must confirm the DIN and monograph at dispensing.

Exact brand entries and DINs for Canadian market authorisations are not specified in the supplied regulatory extract.

Notable Off-Label Trends In Canadian Practice

Off-label use is common for insomnia, agitation in dementia (used cautiously), and as an adjunct for SSRI-resistant depression, typically at lower bedtime doses.

Clinicians commonly prescribe 25–100 mg at night for sleep and document rationale when deviating from labelled indications.

Provincial formularies differ in coverage; some public plans reimburse specific DIN-listed generics under criteria and therapeutic substitution rules.

Prescribers are advised to monitor sedation, falls and interactions closely when using trazodone off-label in older adults.

General Dosing Per Health Canada Monographs

For major depressive disorder, the standard adult starting dose is around 150 mg per day in divided doses.

Outpatient titration commonly reaches 400 mg per day and inpatient care may use doses up to 600 mg per day according to global monographs.

For insomnia, prescribers typically use 25–100 mg at bedtime and generally do not exceed 150 mg for sleep indications.

Condition-Specific Dosing Adjustments

Elderly patients should start at lower doses and titrate slowly because of increased sedation and orthostatic hypotension risk; a common starting dose for sleep is 25–50 mg nightly.

Hepatic impairment and significant renal dysfunction warrant dose reduction and closer monitoring since hepatic CYP metabolism affects plasma levels.

If co-prescribing with strong CYP3A4 inhibitors, consider dose adjustment or choose an alternative agent due to increased trazodone exposure risk.

When discontinuing trazodone, gradual tapering is recommended to reduce withdrawal symptoms.

Contraindications (Canadian Advisories)

Absolute contraindications include known hypersensitivity to trazodone and concurrent or recent MAOI use within 14 days.

Avoid initiation during the acute recovery phase following myocardial infarction.

These contraindications align with international regulatory monographs.

Adverse Effects (Post-Market Reports)

Common mild to moderate adverse effects include drowsiness, dry mouth, dizziness, blurred vision, constipation and headache.

Orthostatic hypotension and falls are notable concerns in older adults, especially when combined with benzodiazepines, opioids or other sedatives.

Rare serious events reported post-market include priapism, serotonin syndrome when combined with other serotonergic agents, and cardiac arrhythmias.

Pharmacists and prescribers should monitor younger patients for suicidality and always report serious adverse events to provincial pharmacovigilance systems.

Food Interactions Common In Canadian Diet

Trazodone has limited direct food interactions, but high-fat meals may alter the absorption of immediate-release tablets and affect onset of sedation.

Counsel patients to take doses at consistent times relative to meals to limit variability in effect, especially when using trazodone for sleep.

Alcohol potentiates sedation and orthostatic effects and should be avoided while taking trazodone.

Drug Combinations Flagged By Health Canada

Strong CYP3A4 inhibitors such as certain azole antifungals, macrolide antibiotics and some antiretrovirals can increase trazodone exposure and require monitoring or dose adjustment.

Concurrent use with other serotonergic drugs, including SSRIs, SNRIs, triptans and MAOIs, raises the risk of serotonin syndrome.

Additive sedation occurs with opioids, benzodiazepines and first-generation antihistamines and is a frequent cause for pharmacy safety alerts in chain dispensing systems.

Antihypertensive drugs may have additive hypotensive effects with trazodone and increase fall risk in older adults.

Canadian Survey Data

Patient surveys in Canada commonly report that trazodone helps with sleep at low doses and that generic trazodone is affordable and widely available.

Many people notice prompt sedation when taking trazodone at bedtime though mood benefits typically take longer.

Survey respondents cite daytime hangover and dizziness as the most frequent complaints, particularly among older adults.

Forum & Community Pharmacy Trends

Community pharmacists at national chains report regular questions about daytime sedation, orthostatic symptoms and interaction checks for trazodone prescriptions.

Caregiver and dementia-support forums often discuss off-label use for agitation, with repeated cautions about increased falls in frail residents.

Pharmacists routinely advise patients to check provincial coverage and explain differences in pack sizes, pricing and whether a DIN-listed generic is preferred by the public plan.

National Pharmacy Chains

Trazodone is dispensed through major Canadian pharmacy chains including Shoppers Drug Mart, Rexall, Jean Coutu in Quebec and London Drugs, as well as independent pharmacies.

Chain pharmacies use DIN codes to manage formulary listings and to trigger interaction and fall-risk alerts during dispensing.

Online Pharmacy Availability & Provincial Restrictions

Online pharmacies in Canada require a valid prescription and must follow provincial dispensing and telepharmacy regulations when supplying desyrel or generic trazodone.

In our online pharmacy, desyrel is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Patients should be aware that provincial drug plans may only reimburse DIN-listed products, and therapeutic substitution rules vary by region.

Cross-Border US Comparisons

Branded Desyrel and Oleptro prices in the United States have historically been higher, while Canadian access to bulk generics can keep patient costs more moderate.

Personal importation rules restrict bringing medication across borders without appropriate documentation, and coverage differs between countries.

Package formats and available strengths influence per-unit pricing across markets.

Comparison Table Of DIN-Approved Alternatives

Pros And Cons Checklist

• Pros: Dual antidepressant and sedative action, widely available generics, multiple tablet strengths and an oral solution for flexible dosing.
• Cons: Orthostatic hypotension, sedation, CYP3A4 interaction risk, not approved for paediatric use.
• Choice between options depends on comorbidities, drug interactions, provincial formulary coverage and patient priorities such as sleep versus sexual side effects.

Health Canada Approval Process

Products sold in Canada undergo Health Canada review for safety, efficacy and quality and must receive a Drug Identification Number for dispensing and formulary listing.

Manufacturers submit clinical and stability data to support market authorisation and DIN issuance.

DIN And Bilingual Labelling Rules

Approved products include a DIN and must carry bilingual English/French labelling and prescribing information consistent with Health Canada guidance.

Pharmacists verify the DIN, manufacturer and expiry at dispensing and provincial formularies use DINs to determine coverage and therapeutic substitution.

Is Trazodone Available Without A Prescription In Canada?

No, trazodone and branded Desyrel are prescription-only in regular practice and pharmacies require a valid prescription and DIN verification.

How Quickly Will Trazodone Help My Sleep Or Mood?

Sleep effects often appear the first night at low doses of 25–100 mg when used for insomnia.

Antidepressant benefits usually begin in 1–2 weeks with full effect commonly seen by 4–6 weeks.

Will Provincial Drug Plans Cover Trazodone?

Coverage varies by province, by plan and by DIN-listed product; check Ontario Drug Benefit, BC PharmaCare or RAMQ and ask your pharmacist for exact coverage details.

Can I Take Trazodone With My Blood Pressure Or Cholesterol Meds?

Many antihypertensives can have additive hypotensive effects with trazodone, increasing risk of orthostatic hypotension; review all medicines for CYP3A4 interactions and sedative combinations.

What Should I Watch For As An Older Adult?

Older adults should start at low doses, watch for daytime sedation and orthostatic dizziness, and monitor fall risk closely with pharmacist or prescriber support.

Infographics To Include

• Infographic 1: Dosing Ladder showing 25 mg → 150 mg → 400 mg with indications for sleep and depression.
• Infographic 2: Provincial Coverage Snapshot comparing Ontario Drug Benefit, RAMQ and BC PharmaCare coverage approaches.
• Infographic 3: Drug Interaction Map highlighting CYP3A4, serotonergic agents and sedative classes.
• Infographic 4: Risk Stratification For Older Adults with fall risk and orthostasis callouts.
• Design Notes: Use DIN-labelled product images of tablets (50–300 mg), bilingual labelling blocks and pharmacy channel icons for Shoppers, Rexall, Jean Coutu and London Drugs.
• Accessibility: Provide ALT text for each infographic and a text-only handout summarising provincial formularies.

Canadian Household Storage Guidelines

Store trazodone at room temperature between 15°C and 30°C, away from moisture and direct light.

Keep tablets in original blister packs or bottles and store oral solutions tightly capped and labelled.

Keep all medications out of the reach of children and in a secure location to prevent accidental ingestion or diversion.

Cold-Chain Storage Where Applicable

Standard trazodone tablets and oral solutions do not require refrigeration and no cold-chain storage is necessary.

When transporting medication between pharmacy and patient or interprovincially, protect from extreme heat or cold with insulated packaging if weather conditions warrant.

Long-term-care dispensing should document DIN, lot number and expiry in accordance with provincial practice standards.

Advice From Canadian Pharmacists

Start trazodone at the lowest effective dose and counsel patients to rise slowly from sitting to reduce orthostatic episodes.

Avoid alcohol and review prescription and non-prescription medicines for interactions, particularly CYP3A4 inhibitors and other sedatives.

Document the indication on the prescription, outline expected timelines for sleep and mood benefit, and schedule follow-up to assess efficacy and adverse effects.

Provincial Health Authority Guidance

Provincial health authorities recommend reporting adverse events to local pharmacovigilance systems and checking provincial formularies for DIN-based coverage rules.

Prescribers should include tapering plans to minimise withdrawal and educate patients on symptoms of serotonin syndrome and priapism, advising urgent care for severe signs.

Delivery Across Canada (English)